107
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparison of Prognosis and Lymph Node Metastasis in T1-Stage Colonic and Rectal Carcinoma: A Retrospective Study

, , , , &
Pages 3651-3662 | Published online: 05 Apr 2022

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. doi:10.3322/caac.21590
  • Li C, Zheng H, Jia H, Huang D, Gu W. Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med. 2019;8:3411–3419. doi:10.1002/cam4.2234
  • Quirke P, Williams GT, Ectors N, Ensari A. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8:651–657. doi:10.1016/S1470-2045(07)70205-X
  • Watanabe T. Current therapeutic strategies for rectal cancer. Int J Clin Oncol. 2015;20:631–632. doi:10.1007/s10147-015-0878-4
  • Benson AB 3rd, Venook AP, Bekaii-Saab T, et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw. 2014;12:1028–1059. doi:10.6004/jnccn.2014.0099
  • Salem ME, Weinberg BA, Xiu J, et al. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget. 2017;8:86356–86368. doi:10.18632/oncotarget.21169
  • Meguid RA, Slidell MB, Wolfgang CL. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388–2394. doi:10.1245/s10434-008-0015-y
  • Kamran SC, Clark JW, Zheng H, et al. Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: results from a large retrospective cohort with mutational analysis. Cancer Med. 2018;7:2934–2942. doi:10.1002/cam4.1558
  • Paschke S, Jafarov S, Staib L, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci. 2018;19. doi:10.3390/ijms19092577
  • Qiu M, Hu J, Yang D, Cosgrove DP, Xu R. Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget. 2015;6:38658–38666. doi:10.18632/oncotarget.6130
  • Chang LC, Shun CT, Lin BR, et al. Recurrence outcomes less favorable in T1 rectal cancer than in T1 colon cancer. Oncologist. 2021;26:e1548–e1554. doi:10.1002/onco.13815
  • Kobayashi H, Mochizuki H, Morita T, et al. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol. 2011;46:203–211. doi:10.1007/s00535-010-0341-2
  • Buchwald P, Hall C, Davidson C, Dixon L, Dobbs B. Improved survival for rectal cancer compared to colon cancer: the four cohort study. ANZ J Surg. 2018;88:E114–e117. doi:10.1111/ans.13730
  • Hemminki K, Försti A, Hemminki A. Survival in colon and rectal cancers in Finland and Sweden through 50 years. BMJ Open Gastroenterol. 2021;8:e000644. doi:10.1136/bmjgast-2021-000644
  • Phipps AI, Lindor NM, Jenkins MA, Baron JA, Win AK, Gallinger S. Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum. 2013;56:937–944. doi:10.1097/DCR.0b013e31828f9a57
  • Aguiar JS, Oliveira MM, Silva D, Mello CAL, Calsavara VF, Curado MP. Survival of patients with colorectal cancer in a cancer center. Arq Gastroenterol. 2020;57:172–177. doi:10.1590/s0004-2803.202000000-32
  • Innos K, Soplepmann J, Suuroja T. Survival for colon and rectal cancer in Estonia: role of staging and treatment. Acta Oncol. 2012;51:521–527. doi:10.3109/0284186X.2011.633928
  • Lee YC, Lee YL, Chuang JP, Lee JC. Differences in survival between colon and rectal cancer from SEER data. PLoS One. 2013;8:e78709. doi:10.1371/journal.pone.0078709
  • Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–188. doi:10.1111/his.13975
  • Jiang K, Zhu Y, Liu Y, Ye Y, Xie Q. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined. Tumour Biol. 2014;35:11685–11690. doi:10.1007/s13277-014-2484-x
  • Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433–441. doi:10.1093/jnci/djk092
  • Fields AC, Lu P, Hu F, Hirji S, Irani J, Bleday R. Lymph node positivity in T1/T2 rectal cancer: a word of caution in an era of increased incidence and changing biology for rectal cancer. J Gastrointest Surg. 2021;25:1029–1035. doi:10.1007/s11605-020-04580-z
  • Nakadoi K, Tanaka S, Kanao H, et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol. 2012;27:1057–1062. doi:10.1111/j.1440-1746.2011.07041.x
  • Takamaru H, Saito Y, Sekiguchi M, et al. Endoscopic resection before surgery does not affect the recurrence rate in patients with high-risk T1 colorectal cancer. Clin Transl Gastroenterol. 2021;12:e00336.
  • Xu X, Zhang C, Ni X, Wu J, Pan C. Population-based analysis on predictors for lymph node metastasis in T1 colon cancer. Surg Endosc. 2020;34:4030–4040. doi:10.1007/s00464-019-07192-0
  • Okabe S, Shia J, Nash G, et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg. 2004;8:1032–1039; discussion 1039–1040. doi:10.1016/j.gassur.2004.09.038
  • Hugen N, Brown G, Glynne-Jones R. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016;13:361–369. doi:10.1038/nrclinonc.2015.140
  • Corrò C, Dutoit V, Koessler T. Emerging trends for radio-immunotherapy in rectal cancer. Cancers. 2021;13:1374. doi:10.3390/cancers13061374
  • Mochizuki K, Kudo SE, Ichimasa K, et al. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study. Int J Colorectal Dis. 2020;35:1911–1919. doi:10.1007/s00384-020-03668-x
  • Aytac E, Gorgun E, Costedio MM, Stocchi L. Impact of tumor location on lymph node metastasis in T1 colorectal cancer. Langenbecks Arch Surg. 2016;401:627–632. doi:10.1007/s00423-016-1452-x
  • Nascimbeni R, Burgart LJ. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45:200–206. doi:10.1007/s10350-004-6147-7
  • Yamashita K, Oka S, Tanaka S, et al. Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis. J Gastroenterol. 2019;54:897–906. doi:10.1007/s00535-019-01590-w
  • Tamaru Y, Oka S, Tanaka S, et al. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol. 2017;52:1169–1179. doi:10.1007/s00535-017-1318-1
  • Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi64–72. doi:10.1093/annonc/mdt354
  • Morino M, Risio M, Bach S, et al. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc. 2015;29:755–773. doi:10.1007/s00464-015-4067-3
  • Tang CT, Chen Y, Zeng C. Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis. Aging. 2020;12:22059–22077. doi:10.18632/aging.104048